BMS-599626
BMS-599626 (AC480) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC50s of 20 and 30 nM, respectively. BMS-599626 displays ~8-fold less potent to HER4 (IC50=190 nM), >100-fold to VEGFR2, c-Kit, Lck, MEK. BMS-599626 inhibits tumor cell proliferation, and has potential to increase tumor response to radiotherapy[1][2].
Product Specifications
CAS Number
714971-09-2
Product Name Alternative
AC480
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-599626.html
Purity
98.56
Solubility
DMSO : 110 mg/mL (ultrasonic)
Smiles
O=C(NC1=CN2C(C(NC3=CC4=C(N(CC5=CC=CC(F)=C5)N=C4)C=C3)=NC=N2)=C1C)OC[C@H]6NCCOC6
Molecular Formula
C27H27FN8O3
Molecular Weight
530.55
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Citation 01
BMC Pulm Med. 2023 May 11;23 (1) :162.|Sci Transl Med. 2018 Jul 18;10 (450) :eaaq1093.|Life Sci. 2021 Dec 16;289:120231.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
N- (15,16-Dihydroxy-4,7,10,13-tetraoxahexadecyl) -2,2,2-trifluoroacetamide
N- (15,16-Dihydroxy-4,7,10,13-tetraoxahexadecyl) -2,2,2-trifluoroacetamide
N- (15,16-Dihydroxy-4,7,10,13-tetraoxahexadecyl) -2,2,2-trifluoroacetamide